5Pottier P,Cormier G,Truchaud F,et al.Antiphospholipid syndrome in the structure of hematogenic thrombophilia in young and middle-aged patients with venous thrombosis thrombosis.Ter Arkh,2005,77:47-51.
6Nakamura N,Ban T,Yamaji K,et al.Localization of the apot-osis-inducing activity of lupus anticoagulant in an V-binding antibody subset.J Clin Invest,1998,101:1951-1959.
3Horstman LL,Jy W,Jimenez JJ,et al.Endothelial microparticles as markers of endothelial dysfunction.Front Biosci,2004,1:1118-1135.
4Jude EB,Douglas JT,Anderson SG,et al.Circulating cellular adhesion molecules ICAM-1,VCAM-1,P-and E-selectin in the prediction of cardiovascular disease in diabetes mellitus.Eur J Intern Med,2002,13:185-189.
5Pericleous C,Giles I,Rahman A.Are endothelial microparticles potential markers of vascular dysfunction in the antiphospholipid syndrome?Lupus,2009,18:671-675.
7Boos CJ,Balakrishnan B,Lip GY.The effects of exercise stress testing on soluble E-selectin,von Willebrand factor,and circulating endothelial cells as indices of endothelial damage/dysfunction.Ann Med,2008,40:66-73.
9Pottier P,Cormier G,Truchaud F,et al.Antiphospholipid syndrome in the structure of hematogenic thrombophilia in young and middle-aged patients with venous thrombosis.Ter Arkh,2005,77:47-51.
10Afeltra A,Vadacca M,Conti L,et al.Thrombosis in systemic lupus erythematosus:congenital and acquired risk factors.Arthritis Rheum,2005,53:452-459.
